A new era for T-cell immune function assays in transplantation

Tissue Antigens

Volumn 75, Issue 6, 2010, Pages 658-667

  Reinsmoen, N L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Carboxyfluorescein diacetate succinimidyl ester mixed lymphocyte reaction; Cell culture assays; Cytotoxic T lymphocyte precursor; Enzyme linked immunosorbent spot; ImmuKnow; Mixed leukocyte culture

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALEMTUZUMAB; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; HLA ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PERFORIN; RAPAMYCIN; STEROID; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; B LYMPHOCYTE ACTIVATION; BACTERIAL PNEUMONIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; GRAFT FAILURE; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTESTINE TRANSPLANTATION; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MIXED LEUKOCYTE CULTURE; MIXED LYMPHOCYTE REACTION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; IMMUNOLOGY;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOASSAY; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION IMMUNOLOGY;

EID: 77952161343     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01441.x     Document Type: Review

References (47)

1. Reinsmoen NL. Cellular methods used to evaluate the immune response transplantation. Tissue Antigens 2002 : 59 : 241 250.
2. Segall M, Noreen H, Edwins L et al. Lack of correlation of MLC reactivity with acute graft-vs-host disease and mortality in unrelated donor bone marrow transplantation. Hum Immunol 1996 : 49 : 49 55.
3. Hutchinson IV, Pravica V, Sinnot PJ. Genetic regulation of cytokine synthesis. Consequences for acute and chronic organ allograft rejection. Graft 1998 : 1 : 186.
4. Warle MC, Farhan A, Metselaar HJ et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transplant 2003 : 9 : 170.
5. Suresh V, Carey BS, Shaw S et al. A retrospective study of the prognostic impact of cytokine secretion in mixed lymphocyte culture on long-term graft function following allogenic renal transplantation. Transplant Int 2005 : 18 : 1067 1071.
6. Kaminski ER, Kaminski A, Bending MR et al. In vitro cytokine profiles and their relevance to rejection following renal transplantation. Transplantation 1995 : 60 : 703.
7. Cartwright NH, Demain AG, McGonigle RJ et al. Cytokine secretion in mixed lymphocyte culture: a prognostic indicator of renal allograft rejection in addition to HLA mismatching. Transplant Immunol 2000 : 8 : 109.
8. Tanaka Y, Ohdan H, Onoe T et al. Low incidence of acute rejection after living-donor transplantation: immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique. Transplantation 2005 : 9 : 1262 1267.
9. Nitta Y, Nelson K, Andrews RG et al. CFSE dye dilution mixed lymphocyte reactions quantify donor-specific alloreactive precursors in non-human primate cardiac graft rejection. Transplant Proc 2001 : 33 : 326.
10. Tanaka Y, Ohdan H, Onoe T et al. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation. Immunol Invest 2004 : 33 : 309.
11. Bloom DD, Hu H, Fechner JH, Knechtle SJ. T-Lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation 2006 : 81 : 81 7.
12. Kreijveld E, Koenen Hans JPM, van Cranenbroek B, van Rijssen E, Joosten I, Hilbrands BL. Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of Tacrolimus. PLoS ONE 2008 : 3 : e2711.
13. Fanning LR, Hegerfeldt Y, Tary-Lehmann M et al. Allogeneic transplantation of multiple umbilical cord blood units in adults: role of mixed lymphocyte reaction to predict host-vs-graft rejection. Leukemia 2008 : 22 : 1786 1790.
14. Sharrock CE, Kaminski E, Man S. Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 1990 : 11 : 281 286.
15. Speiser DE, Loliger CC, Siren MK, Jeannet M. Cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT. Br J Haematol 1996 : 93 : 935 939.
16. van Besouw NM, van der Mast BJ, de KP et al. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppresive therapy can be safely reduced. Transplantation 2000 : 70 : 136 143.
17. Steinmann J, Kaden J, May G et al. Failure of in vitro T-cell assays to predict clinical outcome after human kidney transplantation. J Clin Lab Anal 1994 : 8 : 157 162.
18. van der Mast BJ, Rischen-Vos J, de Kuiper P, Vaessen LMB, van Besouw NM, Weimar W. Calcineurin inhibitor withdrawal in stable kidney transplant patients decreases the donor-specific cytotoxic T lymphocyte precursor frequency. Transplantation 2005 : 80 : 1220 1225.
19. van de Wetering J, van der Mast BJ, de Kuiper P et al. Reduction of immunosuppressive load-in renal transplant recipients with a low donor-specific cytotoxic T-lymphocyte precursor frequency is safe. Transplant Proc 2005 : 37 : 779 781.
20. Wang T, Chen L, Ahmed EM et al. Prevention of allograft tolerance by bacterial infection with listeria monocytogenes. J Immunol 2008 : 180 : 5991 5999.
21. van Besouw NM, Zuijderwijk JM, de Kuiper P, Ijzermans JNM, Weimar W, van der Mast BJ. The granzyme B and interferon-γ enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor-frequency after renal transplantation. Transplantation 2005 : 79 : 1062.
22. Poggio ED, Augustine JJ, Clemente M et al. Cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation 2007 : 83 : 847 852.
23. Andree H, Nickel P, Nasiadko C et al. Identification of dialysis patients with panel-reactive memory T cells before kidney transplantation using an allogeneic cell bank. J Am Soc Nephrol 2006 : 17 : 573 580.
24. Augustine JJ, Siu DS, Clemente MJ, Schulak JA, Heeger PS, Hricik DE. Pretransplant IFN-γ ELISPOTs are associated with posttransplant renal function in African American renal transplant recipients. Am J Transplant 2005 : 5 : 1971 1975.
25. Truong DQ, Cornet A, Wieers G, Robert A, Reding R, Latinne D. Pre- and posttransplant monitoring of granzyme B enzyme-linked immunosorbent spot assay in pediatric liver recipients. Transplant Immunol 2008 : 19 : 215 219.
26. Augustine JJ, Poggio ED, Heeger PS, Hricik D. Preferential benefit of antibody induction therapy in kidney recipients with high frequencies of donor reactive interferon-γ enzyme-linked immunosorbent spots. Transplantation 2008 : 86 : 529 534.
27. Reinsmoen NL, Cornett KMM, Kloehn R et al. Donor specific and non-specific immune parameters associated with early acute rejection. Transplantation 2008 : 85 : 462 470.
28. Tambur AR, Ben-Ari Z, Herrera ND, Klein T, Michowiz R, Mor E. Donor-specific hyporesponsiveness in ELISPOT assay is associated with early recurrence of hepatitis C in liver transplant recipients. Hum Immunol 2005 : 66 : 21 7.
29. Sundaresan S, Alevy YG, Steward N et al. Cytokine gene transcripts for tumor necrosis factor-alpha, interleukin-2, and interferon gamma in human pulmonary allografts. J Heart Lung Transplant 1995 : 14 : 512 518.
30. Hodge G, Flower R, Han P. Australian plasma-derived factor VIII concentrate inhibits Th1 type cytokines but increases Th2 type cytokine, IL-10. Br J Haematol 2000 : 109 : 902 903.
31. Hodge G, Han P. Factor VIII concentrate inhibits T-helper-type 2 (Th2) cytokine production in vitro: relevance to inhibitor antibody formation. Haemophilia 2001 : 7 : 490 496.
32. Hodge G, Hodge S, Reynolds P, Holmes M. Intracellular cytokines in blood T cells in lung transplant patients - a more relevant indicator of immunosuppresion than drug levels. British Society for Immunology. Clin Exp Immunol 2005 : 139 : 159 164.
33. Hodge G, Hodge S, Reynolds PN, Holmes M. Increased intracellular pro- and anti-inflammatory cytokines in bronchoalveolar lavage T cells of stable lung transplant patients. Transplantation 2005 : 80 : 1040 1045.
34. Hodge G, Hodge S, Reynolds PN, Holmes M. Up-regulation of interleukin-8, interleukin-10, monocyte chemotactic protein-1, and monocyte chemotactic protein-3 in peripheral blood monocytes in stable lung transplant recipients: are immunosuppression regimens working? Transplantation 2005 : 79 : 387 391.
35. Toyoda M, Pao A, Vo A et al. Intracellular IFNγ production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization. Transplant Immunol (in press).
36. Macedo C, Orkis EA, Popescu I et al. Contribution of naïve and memory T-cell populations to the human alloimmune response. Am J Transplant 2009 : 9 : 2057 2066.
37. Kowalski RJ, Post DR, Mannon RB et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006 : 82 : 663 668.
38. Husain S, Raza K, Pilewski JM et al. Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection. Transplantation 2009 : 87 : 1852 1857.
39. Bhorade SM, Janata K, Vigneswaran WT, Alex CG, Garrity ER. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant 2008 : 27 : 990 994.
40. Macedo C, Zeevi A, Bentlejewski C et al. The impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients. Transplantation 2009 : 88 : 123 128.
41. Batal I, Zeevi A, Heider A et al. Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation. Am J Clin Pathol 2008 : 129 : 587 591.
42. Thai NL, Blisard D, Tom K et al. Pancreas transplantation under Alemtuzumab (Campath-lH) and tracolimus: correlation between low T-cell responses and inspection. Transplantation 2006 : 82 : 1649 1652.
43. Zeevi A, Husain S, Spichty KH et al. Recovery of functional memory T cells in lung transplant recipients following induction therapy with Alemtuzumab. Am J Transplant 2007 : 7 : 471 475.
44. Serban G, Whittaker V, Fan J et al. Significance of immune cell function monitoring in renal transplantation following thymoglobulin induction therapy. Hum Immunol 2009 : 70 : 882 890.
45. Zeevi A, Britz JA, Bentlejewski CA et al. Monitoring immune function during Tacrolimus tapering in small bowel transplant recipients. Transplant Immunol 2005 : 15 : 17 24.
46. Knight RJ, Kerman RH, McKissick E et al. Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy. Clin Transplant 2008,.
47. Cadillo-Chavez R, de Echegaray S, Santiago-Delpin EA et al. Assessing the risk of infection and rejection in Hispanic real transplant recipients by means of an adenosine triphosphate release assay. Transplant Proc 2006 : 38 : 918 920.